From the publishers of JADPRO

Acute Lymphoblastic Leukemia Resource Center

Advertisement
FROM THE EDITOR

Welcome to the new Acute Lymphoblastic Leukemia (ALL) Resource Center where we present to you current information, news items, literature, and other resources that focus on ALL and the advanced practitioner’s role in delivering high-quality care.  We’re excited to provide this information to you and your colleagues and hope this site is helpful to your practice. If you have any feedback or questions, please contact jadpro-editor@conexiant.com.

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C, University of Texas MD Anderson Cancer Center

News & Literature Highlights

Medical Journal, Armed Forces India

Bone mineral density in childhood acute lymphoblastic leukaemia survivors and factors affecting it

Clinical and Experimental Pediatrics

Allogeneic stem-cell transplantation following chimeric antigen receptor T-cell therapy for treatment of relapsed/ refractory hematologic malignancy in children and young adults: a systematic review and meta-analysis

Frontiers in Oncology

Impact of standardized immunophenotyping and MRD monitoring on early mortality reduction in childhood leukemia: A step towards addressing healthcare disparities in vulnerable populations from Southern Mexico

Discover Oncology

Combination of venetoclax with CHG regimen in refractory/relapsed T-lymphoblastic lymphoma/acute lymphoblastic leukemia: A case series and literature review

Leukemia

Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: A single-center, single-arm, phase 2 trial

BMC Ophthalmology

Daratumumab-induced acute angle closure glaucoma: bone marrow transplantation as a possible risk factor and atropinization as a potential solution

Pediatrics International: Official Journal of the Japan Pediatric Society

Safety and efficacy of sedation for pediatric patients with cancer and developmental disabilities

Blood Advances

Asciminib for relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia

European Journal of Pediatrics

What about the heart–pediatric ALL survivors show cardiopulmonary limitations in the MinimALL Study

Journal of the National Comprehensive Cancer Network

Genomic classification of T-cell acute lymphoblastic leukemia: Current paradigms and future biomarkers

Advertisement
Advertisement